Clinical Trial

Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline

Study acronym: MDRS
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2025 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Objective from this study to compare the clinical outcomes and safety between colistin and tigecycline for multi-drug resistant gram negative bacteria.
Trial Details
NCT Number NCT06893835
Lead Sponsor Beni-Suef University
Conditions Infection in ICU
Enrollment 132 participants
Start Date 2024-12-01
Primary Completion 2025-05-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-25